With so many shares to choose from on the ASX, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.
Three top ASX shares that leading brokers have named as buys this week are listed below. Here's why they are bullish on them:
Core Lithium Ltd (ASX: CXO)
According to a note out of Macquarie, its analysts have retained their outperform rating and 65 cents price target on this lithium miner's shares. This follows the release of the company's FY 2023 results, which revealed a surprise maiden profit. Macquarie had been expecting Core Lithium to post a loss for the year. It was also pleased to see that its guidance has been maintained for the year ahead. The Core Lithium share price is trading at 42 cents today.
CSL Limited (ASX: CSL)
A note out of Morgan Stanley reveals that its analysts have retained their overweight rating and $334 price target on this biotherapeutics company's shares. The broker highlights that CSL's shares have come under pressure recently, possibly amid concerns over the impending release of a competing generic drug for Injectafer. However, the broker isn't concerned. Particularly given how it sees scope for Injectafer to be used in patient blood management. It feels this could mean higher overall earnings in the future despite the generic competition. The CSL share price is fetching $247.81 this afternoon.
Washington H. Soul Pattinson and Co. Ltd (ASX: SOL)
Analysts at Morgans have retained their add rating on this investment company's shares with an improved price target of $34.75. This follows the release of its FY 2023 results, which revealed a broadly resilient performance. The broker also highlights that FY 2024 should benefit from a more diversified asset base and that its strong cash balance gives it opportunities to take advantage of any potential volatility. The Soul Patts share price is trading at $32.48 today.
